Related Experiment Video
Updated: Apr 5, 2026

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Asymptomatic children might transmit human parechovirus type 3 to neonates and young infants
Yuta Aizawa1, Takayuki Yamanaka2, Kanako Watanabe3
1Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Insights
Asymptomatic children in households can transmit human parechovirus type 3 (HPeV3) to infants. This study identified genetically identical HPeV3 in infected infants and their asymptomatic siblings, suggesting children are a key source of HPeV3 infection.
Area of Science:
- Virology
- Epidemiology
- Pediatrics
Background:
- Human parechovirus type 3 (HPeV3) causes epidemics and severe illness in neonates and infants globally.
- The primary source of HPeV3 infection remains largely unknown.
Purpose of the Study:
- To identify the source of HPeV3 transmission within families.
- To investigate the role of asymptomatic children in the spread of HPeV3.
Main Methods:
- Analysis of clinical data from 43 infants with HPeV3 disease during a 2014 epidemic in Japan.
- PCR testing of stool samples from symptomatic and asymptomatic siblings/cousins of infected infants.
- Sequencing of P1 and 3D(pol) regions of HPeV to confirm transmission.
Main Results:
- Family contact was confirmed in 51% of HPeV3 cases.
- Siblings were the most common symptomatic family contacts (67%).
- Genetically identical HPeV3 strains were found in infected infants and their asymptomatic siblings/cousins.
Conclusions:
- Asymptomatic children in households serve as a significant source of HPeV3 infection.
- This finding is crucial for understanding and preventing HPeV3 transmission in vulnerable neonates and infants.
Background:
Human parechovirus type 3 (HPeV3) epidemics occur worldwide and can lead to severe disease in neonates and young infants. Little is known about the source of HPeV3 infection.
Objectives:
To investigate the source of HPeV3 infection and the role of asymptomatic children in the families of infected children.
Study Design:
During a 2014 HPeV3 epidemic in Niigata, Japan, we analyzed (1) clinical information on sick contacts for 43 neonates and young infants with HPeV3-related disease diagnosed by PCR analysis of serum and/or cerebrospinal fluid and (2) stool samples from symptomatic and asymptomatic siblings/cousins of index patients. To confirm transmission, the P1 (VP0, VP3, and VP1) and 3D(pol) regions of HPeVs were sequenced and analyzed.
Results:
Sick contact with family members was confirmed for 51% (n=22) of patients. Among the 30 symptomatic family members, 67% (n=20) were siblings, 20% (n=6) were mothers, and 13% (n=4) were other relatives. Stool samples from symptomatic and asymptomatic siblings/cousins of 4 HPeV3-infected patients yielded positive results for HPeVs on PCR analysis. Furthermore, the P1 and 3D(pol) nucleotide sequences of family members were 100% identical to those of the respective index cases.
Conclusions:
Identification of genetically identical virus from HPeV3-infected patients and asymptomatic children in their families suggests that the latter are a source of infection in neonates and young infants with HPeV3-related diseases.
More Related Videos
05:53Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Related Concept Videos
Cytomegalovirus Disease
Human Virome
Arboviral Encephalitis
Viral Meningitis
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption